Bigger is not always better: Tumor size and prognosis in advanced melanoma Journal Article

  


Authors: Warner, A. B.; Postow, M. A.
Article Title: Bigger is not always better: Tumor size and prognosis in advanced melanoma
Abstract: Tumor burden is a key consideration for the treatment of solid malignancies. Large baseline tumor size (an assessment of volume of disease in target lesions prior to treatment), elevated lactate dehydrogenase (LDH), and site of disease are prognostic of poor overall survival (OS) for patients with advanced melanoma treated with pembrolizumab. © 2018 American Association for Cancer Research.
Journal Title: Clinical Cancer Research
Volume: 24
Issue: 20
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2018-10-01
Start Page: 4915
End Page: 4917
Language: English
DOI: 10.1158/1078-0432.ccr-18-1311
PUBMED: 29903895
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054995411&doi=10.1158%2f1078-0432.CCR-18-1311&partnerID=40&md5=44900244073dfd07e85978962949d362
Notes: Article -- Export Date: 1 November 2018 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Michael Andrew Postow
    361 Postow
  2. Allison Betof Warner
    76 Betof Warner
Related MSK Work